Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease

doi:10.3748/wjg.v23.i22.3954

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (16411)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

1021

WORD

275

HTML

9931

Figures (1-2)

301

Tables (1-1)

239

Sum=11767

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

589

Download

1086

Sum=1675

Publishing Process of This Article

Item

Count

Browse

1194

Download

1775

Sum=2969

Jun 14, 2017 (publication date) through Dec 21, 2024

Times Cited of This Article

Times Cited (60)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jun 14, 2017; 23(22): 3954-3963
Published online Jun 14, 2017. doi: 10.3748/wjg.v23.i22.3954

Full Size Figure Download Figure

Figure 2 First hit and second hit in non-steroidal anti-inflammatory drugs enteropathy[21].

Citation: Utzeri E, Usai P. Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease. World J Gastroenterol 2017; 23(22): 3954-3963
URL: https://www.wjgnet.com/1007-9327/full/v23/i22/3954.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i22.3954